Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
British Journal of Haematology|March 21, 2012
Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cellsKarthik Ramasamy, Hazera Khatun, Lee Macpherson, et al.
European Journal of Ophthalmology|May 11, 2013
Bilateral retinal vasculopathy associated with autosomal dominant dyskeratosis congenitaSara Vaz-Pereira, Patricio A Pacheco, Shreyans Gandhi, et al.
British Journal of Haematology|July 22, 2014
Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromesMikkael A Sekeres, Aristoteles Giagounidis, Hagop Kantarjian, et al.
Molecular Cancer Research : MCR|August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Transfusion Medicine (Oxford, England)|June 19, 2019
Impact of Human Leucocyte Antigen epitope matched platelet transfusions in alloimmunised aplastic anaemia patientsDelordson Kallon, Cristina V Navarrete, Deborah A Sage, et al.
Elife|October 17, 2024
Expression of most retrotransposons in human blood correlates with biological agingYi-Ting Tsai, Nogayhan Seymen, I Richard Thompson, et al.
Oncotarget|July 5, 2016
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesisHeba A Alkhatabi, Donal P McLornan, Austin G Kulasekararaj, et al.
The Journal of Infection|June 26, 2016
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantationM Mansour Ceesay, Shahram Kordasti, Eamaan Rufaie, et al.
Blood|June 14, 2013
Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndromeAzim M Mohamedali, Heba Alkhatabi, Austin Kulasekararaj, et al.
Blood|August 15, 2002
Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumabAndrea G S Buggins, Ghulam J Mufti, Jonathan Salisbury, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
British Journal of Haematology|March 21, 2012
Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cellsKarthik Ramasamy, Hazera Khatun, Lee Macpherson, et al.
European Journal of Ophthalmology|May 11, 2013
Bilateral retinal vasculopathy associated with autosomal dominant dyskeratosis congenitaSara Vaz-Pereira, Patricio A Pacheco, Shreyans Gandhi, et al.
British Journal of Haematology|July 22, 2014
Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromesMikkael A Sekeres, Aristoteles Giagounidis, Hagop Kantarjian, et al.
Molecular Cancer Research : MCR|August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Transfusion Medicine (Oxford, England)|June 19, 2019
Impact of Human Leucocyte Antigen epitope matched platelet transfusions in alloimmunised aplastic anaemia patientsDelordson Kallon, Cristina V Navarrete, Deborah A Sage, et al.
Elife|October 17, 2024
Expression of most retrotransposons in human blood correlates with biological agingYi-Ting Tsai, Nogayhan Seymen, I Richard Thompson, et al.
Oncotarget|July 5, 2016
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesisHeba A Alkhatabi, Donal P McLornan, Austin G Kulasekararaj, et al.
The Journal of Infection|June 26, 2016
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantationM Mansour Ceesay, Shahram Kordasti, Eamaan Rufaie, et al.
Blood|June 14, 2013
Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndromeAzim M Mohamedali, Heba Alkhatabi, Austin Kulasekararaj, et al.
Blood|August 15, 2002
Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumabAndrea G S Buggins, Ghulam J Mufti, Jonathan Salisbury, et al.
Pageof 23